Find research datasets worth reusing

opennotspecifiedMar 2021View details →

Fig. 2 in Panduratins Q-Y, dimeric metabolites from Boesenbergia rotunda and their antiausterity activities against the PANC-1 human pancreatic cancer cell line

Fig. 2. Connectivities (bold lines) deduced by the COSY spectrum and significant HMBC correlations (solid arrows) observed for 1–9.

opennotspecifiedFeb 2021View details →

Fig. 2 in (þ/¡)-Dievodialetins A¡G: Seven pairs of enantiomeric coumarin dimers with anti-acetylcholinesterase activity from the roots of Evodia lepta Merr.

Fig. 2. (A) Key 1H–1H COSY (red bold lines) and HMBC (blue arrows) correlations of 1. (B) X-ray ORTEP schematic of 1. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

opennotspecifiedFeb 2021View details →

Fig. 5. Compounds 1–9 in (þ/¡)-Dievodialetins A¡G: Seven pairs of enantiomeric coumarin dimers with anti-acetylcholinesterase activity from the roots of Evodia lepta Merr.

Fig. 5. Compounds 1–9 ameliorate oxidative stress and neuroinflammation in scopolamine-treated SH-SY5Y cells.

opennotspecifiedJan 2021View details →

Fig. 1 in 1,3-Dioxepine and spiropyran derivatives of viomellein and other dimeric naphthopyranones from cultures of Aspergillus elegans KUFA0015 and their antibacterial activity

Fig. 1. Structures of specialised metabolites isolated from the cultures of the marine sponge-associated fungus Aspergillus elegans KUFA0015.

opennotspecifiedJan 2021View details →

Fig. 7 in 1,3-Dioxepine and spiropyran derivatives of viomellein and other dimeric naphthopyranones from cultures of Aspergillus elegans KUFA0015 and their antibacterial activity

Fig. 7. Models of 6 representing the two lowest energy conformations of the central ring (groups G1, left, and G2, right) as well as the lowest energy transition state model TS for the conversion between G1 and G2. For correct 3D interpretation of these projections, consider the H-11 nuclei nearer to the observer and the methoxy groups farther from the observer.

opennotspecifiedJan 2021View details →

Fig. 6 in 1,3-Dioxepine and spiropyran derivatives of viomellein and other dimeric naphthopyranones from cultures of Aspergillus elegans KUFA0015 and their antibacterial activity

Fig. 6. Expansion and assignments of 1H NMR spectra of H-11 geminal nuclei, Ha and Hb, at two different temperatures, in DMSO‑d6, at 500 MHz. The measured scalar coupling constant of 5 Hz is within the typical range for geminal protons. Assignments refer to labels used in Fig. 7.

opennotspecifiedMar 2023View details →

Fig. 7 in Dimeric aporphine alkaloids from the twigs of Trivalvaria costata (Hook.f. & Thomson) I.M.Turner

Fig. 7. ECD spectra (MeOH) of compounds ()-(7), (+)-(7), (±)-8, (±)-9, (±)-10, ()-(11), (+)-(11), ()-(12), (+)-(12), ()-(13), (+)-(13), ()-(14), and (+)-(14).

opennotspecifiedMar 2023View details →

Fig. 5 in Dimeric aporphine alkaloids from the twigs of Trivalvaria costata (Hook.f. & Thomson) I.M.Turner

Fig. 5. ECD spectra (MeOH) of compounds ()-(1), (+)-(1), ()-(2), (+)-(2), ()-(3), (+)-(3), (+)-(4), ()-(5), (+)-(5), ()-(6), and (+)-(6).

opencc-by-4.0Sep 2023View details →

Input Files for Phospholipids are imported into mitochondria by VDAC, a dimeric beta barrel scramblase

<p>Input files for simulations in publication: Helene Jahn, Ladislav Barto&scaron;, Grace I. Dearden, Jeremy S. Dittman, Joost C. M. Holthuis, Robert Vácha, Anant K. Menon: Phospholipids are imported into mitochondria by VDAC, a dimeric beta barrel scramblase</p>

controlledIPD-YESFeb 2026View details →

Phase 1B Study of KSP/QRH Dimer for Detection of Neoplasia in the Esophagus

ClinicalTrials.gov study NCT03852576. IPD Sharing: YES. Countries: 1. Publications: 1.

D-dimer Testing Tailored to Clinical Pretest Probability in Suspected Pulmonary Embolism

ClinicalTrials.gov study NCT02483442. IPD Sharing: Not stated. Countries: 1. Publications: 1.

The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)

ClinicalTrials.gov study NCT00924859. IPD Sharing: Not stated. Countries: 2. Publications: 1.

To Assess the Predictive Value of D-dimer Level on the Occurrence of Cardiovascular Events

ClinicalTrials.gov study NCT01224574. IPD Sharing: Not stated. Countries: 1. Publications: 4.

Ductus Arteriosus Closure and D-Dimer and Fibrinogen Levels

ClinicalTrials.gov study NCT04508036. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

ClinicalTrials.gov study NCT00720915. IPD Sharing: Not stated. Countries: 4. Publications: 3.

Age-adjusted D-dimer Cut-off Levels to Rule Out Pulmonary Embolism

ClinicalTrials.gov study NCT01134068. IPD Sharing: Not stated. Countries: 3. Publications: 1.

Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis

ClinicalTrials.gov study NCT00437892. IPD Sharing: Not stated. Countries: 1. Publications: 2.

D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence

ClinicalTrials.gov study NCT00266045. IPD Sharing: Not stated. Countries: 1. Publications: 3.

Selective D-Dimer Testing Compared With Uniform D-Dimer Testing in the Diagnosis of Deep Vein Thrombosis (SELECT)

ClinicalTrials.gov study NCT00157677. IPD Sharing: Not stated. Countries: 1. Publications: 1.

D-Dimer Vs Serial Compression Ultrasound Study

ClinicalTrials.gov study NCT00182351. IPD Sharing: Not stated. Countries: 1. Publications: 1.